Want to join the conversation?
$COL said that its R&D expenses decreased from $231MM in 1Q15 to $228MM during 1Q16. The company funded R&D decreased $17MM due to lower development expenditures for the Embraer Legacy 450 and the Airbus A350, as well as lower business jet product line development costs.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?